U.S. Stock
Funds
Bonds
Forex
Cryptocurrencies
Macroeconomics
Style and Discipline
Policy & Regulation
U.S. Stock
Dec 20, 2024
Aadi Bioscience stock soars on licensing and sale deals
-- Aadi Bioscience, Inc. (NASDAQ:AADI) shares surged 24% in pre-open trading Friday following the company's announcement of a strategic licensing agreement and a...
READ MORE
Dec 20, 2024
UK watchdog flags competition concerns over Synopsys-Ansys deal
-- Synopsys Inc (NASDAQ:SNPS).'s proposed $35 billion acquisition of software developer Ansys (NASDAQ:ANSS) Inc. has come under scrutiny by the UK's Competition and...
READ MORE
Dec 20, 2024
These 5 stocks are latest addition to Jefferies' Franchise Picks list
-- Jefferies has unveiled the latest update to its Franchise Picks list, adding five new high-conviction stocks: Caterpillar (NYSE:CAT), EPAM Systems, Flowserve...
READ MORE
Dec 20, 2024
Viking Therapeutics stock surges 12% amid Novo Nordisk trial woes
-- Shares of Viking Therapeutics (NASDAQ: NASDAQ:VKTX) soared 12% following the announcement that Novo Nordisk's (NYSE: NYSE:NVO) obesity drug trial yielded...
READ MORE
Dec 20, 2024
Volkswagen closer to agreement with labor leaders - Reuters
-- Volkswagen (ETR:VOWG_p) is reportedly nearing a deal with labor leaders following its longest ever negotiation period, as the company seeks to implement cost...
READ MORE
Dec 20, 2024
Humacyte stock surges over 50% on FDA approval
-- Shares of Humacyte Inc. soared +56% in pre-open trading Friday following the announcement that the U.S. Food and Drug Administration (FDA) has granted full...
READ MORE
Dec 20, 2024
Russia's Druzhba pipeline oil supply halted since yesterday
-- Oil supplies through Russia's Druzhba pipeline, which links Russian oil fields to European refineries, have been halted since December 19, according to sources...
READ MORE
Dec 20, 2024
Russia's central bank maintains key interest rates at 21%
-- On Friday, Russia's central bank announced that it will keep its primary interest rates steady at 21%. This move was unexpected, as the market had widely predicted...
READ MORE
Dec 20, 2024
Ionis stock rises following FDA approval of TRYNGOLZA
-- Ionis Pharmaceuticals (NASDAQ:IONS) shares climbed 6% in pre-open trading Friday after announcing the U.S. Food and Drug Administration (FDA) approval of...
READ MORE
Dec 20, 2024
Bitcoin tumbles amid risk-off sentiment
-- Bitcoin's value plummeted approximately 9% on Friday, as the cryptocurrency market experienced a sharp sell-off, possibly reflecting a broader investor retreat...
READ MORE